Lack of insurance cause of survivorship gap in minorities with cancer, study shows

University of Illinois Cancer Center member Greg Calip led a new study that found lack of insurance coverage is a major cause of delayed breast cancer screening and treatment among minority women, which could lead to a decrease in a patient’s chance of survival. Dr. Susan Hong, director of survivorship at the UI Cancer Center, assisted Calip in the study, as did researchers at the Boston Medical Center/Boston University School of Medicine. Read…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following study has recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about a study, please email cancertrials@uic.edu or call 312-355-5112. ACT16105: An Open Label Randomized Phase 2 Trial of SAR439859, Versus Endocrine Monotherapy as Per Physician’s Choice in Premenopausal and Postmenopausal Patients With…

Continue Reading

ChicagoCHEC accepting applications for summer program

Applications are currently being accepted for the 2020 ChicagoCHEC (Cancer Health Equity Collaborative) summer fellowship program. Application deadline is Feb. 28. Finalists will be selected and interviewed in March, with candidates being chosen and notified in April. The program begins on June 15 and ends on August 7. Learn more here. Apply here.

Continue Reading

Funding opportunity

The PhRMA (Pharmaceutical Research and Manufacturers of America) Foundation is accepting applications for funding in Health Outcomes Research and Translational Medicine. The Health Outcomes Research program offers pre- and post-doctoral fellowships and research starter grants, while the Translational Medicine program offers post-doctoral fellowships and research starter grants. Application deadline is Feb. 3 at 11:59 p.m. EST. Recipients of awards will be notified no later than April 15. Visit here for more information or…

Continue Reading

Funding opportunities

As a result of the Policy, Practice and Prevention Research Center's (P3RC) funding from the CDC Prevention Research Center Program for the 9/30/2019 to 9/29/2024 cycle, UIC investigators are now eligible to apply for 2020 Special Interest Project Competitive Supplements (SIPS). Please email Amber Uskali, Deputy Director, adimasc2@uic.edu and Lisa Powell, Director and Cancer Center member, at powelll@uic.edu no later than this Friday, January 10th if you would like to apply for any of the SIP projects listed below. Only…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following study has recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about a study, please email cancertrials@uic.edu or call 312-355-5112. A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients With Previously Untreated Metastatic Colorectal Cancer (SOLARIS) Sponsor: Alliance for Clinical…

Continue Reading

Paskett featured speaker at Distinguished Lecture Series

Electra Paskett, a nationally recognized leader in the study of cancer health disparities, will be the featured speaker at the University of Illinois Cancer Center’s Distinguished Lecture Series, to be held on Thursday, Jan. 16, from 2:30 p.m. to 3:30 p.m. in Moss Auditorium, College of Medicine Research Building, Room 1020, 909 S. Wolcott Ave. A reception will follow. Paskett, PhD, will discuss “A Multi-Level Model to Address Cervical Cancer Disparities in Appalachia.…

Continue Reading

Gantt latest member of UI Cancer Center

Dr. Gerald Gantt Jr., assistant professor of surgery in the Division of Colon and Rectal Surgery at the University of Illinois College of Medicine, has joined the University of Cancer Center as a member. Gantt specializes in the treatment of colon and rectal cancer, inflammatory bowel disease, anorectal disorders and diverticular disease. His research interests include colorectal cancer genomics, novel surgical techniques and health disparities. Gantt received his undergraduate degree from Atlanta’s Morehouse…

Continue Reading

Welcome, Wonhwa

Wonhwa Cho is not new to the University of Illinois at Chicago, but he is to the University of Illinois Cancer Center. Cho, PhD, the Liberal Arts and Sciences Science Endowed Chair, UIC distinguished professor, and head of the department of chemistry, is one of the newest members to join the UI Cancer Center. He joined the department of chemistry as an assistant professor in 1990. He received both a bachelor’s and master’s…

Continue Reading

New paper shows differences in location

University of Illinois Cancer Center member Greg Calip served as co-author on a new study that showed regional differences in improved survival of patients with de novo metastatic breast cancer over time. The work was published in the journal Cancer. Calip, PharmD, MPH, PhD, and his colleagues studied patients in the Surveillance, Epidemiology, and End Results (SEER) 9 population and an institutional cohort with de novo metastatic breast cancer (MBC), which is a…

Continue Reading